GRIGIONI, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 4.362
AS - Asia 3.556
EU - Europa 2.511
SA - Sud America 213
AF - Africa 184
Continente sconosciuto - Info sul continente non disponibili 124
OC - Oceania 3
Totale 10.953
Nazione #
US - Stati Uniti d'America 4.297
SG - Singapore 1.047
VN - Vietnam 1.033
CN - Cina 820
GB - Regno Unito 630
DE - Germania 367
SE - Svezia 326
HK - Hong Kong 238
IT - Italia 222
FR - Francia 207
BR - Brasile 157
RU - Federazione Russa 152
IN - India 149
UA - Ucraina 149
IE - Irlanda 113
NL - Olanda 100
CH - Svizzera 66
JP - Giappone 50
TG - Togo 49
ZA - Sudafrica 48
EE - Estonia 44
KR - Corea 44
FI - Finlandia 39
CI - Costa d'Avorio 35
CA - Canada 32
BE - Belgio 28
JO - Giordania 28
SC - Seychelles 26
AR - Argentina 24
BD - Bangladesh 23
TH - Thailandia 22
BG - Bulgaria 19
PH - Filippine 19
MX - Messico 16
IQ - Iraq 15
IR - Iran 14
NG - Nigeria 12
PL - Polonia 10
PK - Pakistan 8
TW - Taiwan 8
CL - Cile 7
CO - Colombia 7
EC - Ecuador 7
ES - Italia 7
GR - Grecia 7
ID - Indonesia 6
MY - Malesia 6
AT - Austria 5
RO - Romania 5
TR - Turchia 5
JM - Giamaica 4
PY - Paraguay 4
TN - Tunisia 4
AU - Australia 3
AZ - Azerbaigian 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
LB - Libano 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
NO - Norvegia 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BO - Bolivia 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GI - Gibilterra 1
GN - Guinea 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RW - Ruanda 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 10.831
Città #
Singapore 693
Southend 542
Ashburn 418
Fairfield 387
Chandler 328
San Jose 269
Hong Kong 227
Woodbridge 212
Ho Chi Minh City 198
Dong Ket 185
Wilmington 184
Seattle 179
Houston 168
Hanoi 163
Princeton 161
Ann Arbor 149
Cambridge 147
Santa Clara 129
Dublin 113
Beijing 109
Hefei 105
Jacksonville 105
Boardman 102
Council Bluffs 90
Lauterbourg 80
Berlin 67
Los Angeles 65
Bern 57
Nanjing 51
Westminster 51
Padova 50
Lomé 49
Dallas 47
Tokyo 45
New York 37
Abidjan 35
Haiphong 35
Helsinki 34
Saint Petersburg 34
Jinan 33
Buffalo 32
Bologna 31
Frankfurt am Main 31
Seoul 31
Amman 28
Bremen 27
Brussels 27
Shenyang 25
Guangzhou 24
San Diego 24
São Paulo 24
Redmond 23
Milan 22
Redondo Beach 22
Tianjin 20
Changsha 18
Da Nang 18
Munich 18
Mülheim 18
Nanchang 18
Sofia 18
Dearborn 17
Chicago 16
San Francisco 15
Shanghai 15
Brooklyn 14
Des Moines 14
Turin 14
Mahé 13
Haikou 12
Orem 12
Abeokuta 11
Falkenstein 11
Florence 11
Hải Dương 11
Paris 11
Toronto 11
Baghdad 10
Bangkok 10
Hebei 10
Montreal 10
Zhengzhou 10
Falls Church 9
Mexico City 9
Jiaxing 8
Medford 8
Norwalk 8
Redwood City 8
Verona 8
Bengaluru 7
Can Tho 7
Düsseldorf 7
Elk Grove Village 7
Kunming 7
London 7
Ningbo 7
Ninh Bình 7
Nuremberg 7
Roubaix 7
Shijiazhuang 7
Totale 7.025
Nome #
Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy 342
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 333
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. 242
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 242
11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. 238
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. 235
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 214
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 213
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 213
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 210
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 206
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 204
Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation 197
A histopathologic screening method for rational use of organs from prostate-specific antigen-positive multiorgan donors: the Italian Emilia-Romagna Region experience 190
Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. 186
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer 182
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells. 181
Efficacy and appropriateness of histological score in prediction of the 3-year outcome of kidney transplantation 181
Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines. 180
Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. 178
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 177
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 174
Portal vein arterialization: a new surgical option against acute liver failure? 172
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 170
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples. 170
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis 168
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 166
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. 164
Characterization of small nodules in liver cirrhosis. The assessment of the vascular pattern at imaging techniques. The problem of "hypovascular" HCC 164
Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation. 159
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. 154
Histopathological evaluation of recurrent hepatitis C after liver transplantation: A review 152
The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: A retrospective study. 151
Endoscopic finding of granular cell tumour associated with leiomyomas in the oesophagus. 146
A novel spectral ultrasonic differentiation method for marking regions of interest in biological tissue: in vitro results for prostate. 141
Italian Transplant Research Network. Quality and safety in the Italian donor evaluation process. 137
Expression of beta-galactoside alpha 2,6 sialyltransferase and of alpha 2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis 134
Strategies for evaluation of suitable donors: Italian experience. 132
Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. 131
Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings. 128
Toward the definition of immunosuppressive regimens with antitumor activity. 127
Endothelial cell differentiation in hepatocellular adenomas:implications for histopathological diagnosis. 125
Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation. 121
Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. 120
Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry. 119
Incidence of neoplastic donors in Organizzazione Centro Sud Trapianti area during the 2003-2005 period. 117
Two years' experience of acute rejection monitoring of intestinal transplant recipients by real-time PCR assessment of granzyme B and perforin up-regulation: considerations on diagnostic accuracy. 116
Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients 114
Italian Transplant Research Network. The Italian multiorgan donor cancer screening protocol: 2002-2005 experience. 107
Insulin-like growth factor (IGF) stimulation of hepatocellular carcinoma (HCC) migration is mediated by divergent regulation of aspartyl-asparagyl B hydroxylase (AAH) and notch 105
Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma: An in situ hybridization and immunohistochemical study 104
Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma 101
A multiorgan donor cancer screening protocol: The Italian Emilia-Romagna region experience 94
High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas 93
Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor 93
Role and new perspectives of transforming growth factor-α (TGF-α) in adenocarcinoma of the gastro-oesophageal junction 90
Primary paraganglioma strictly confined to the liver and mimicking hepatocellular carcinoma: An immunohistochemical and in situ hybridization study 85
Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas 85
Expression of insulin‐like growth factor II (IGF–II) in human hepatocellular carcinomas: An immunohistochemical study 85
Expression, regulation, and function of αV integrins in hepatocellular carcinoma: An in vivo and in vitro study 84
Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis 81
Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: An immunohistochemical study on 109 Italian patients 79
Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane 78
Factors affecting recurrence in Crohn's disease: Results of a prospective audit 77
Discrepancies between detection of Bcl-2 by in situ hybridization and immunocytochemistry in human prostate cancer tissues 75
Diagnostic implications of albumin messenger RNA detection and cytokeratin pattern in benign hepatic lesions and biliary cystadenocarcinoma 75
Histogenesis of primary liver carcinomas: Strengths and weaknesses of cytokeratin profile and albumin mRNA detection 72
Granzyme B and perforin as predictive markers for acute rejection in human intestinal transplantation 69
Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: Its specific receptor c- met does 62
Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours 61
The metabolic organization of the adult human liver: A comparative study of normal, fibrotic, and cirrhotic liver tissue 54
Fibrolamellar carcinoma of the liver: Composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules 54
Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease 51
Focal nodular hyperplasia of the liver: Composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules 51
Expression of cadherins and α-catenin in primary epithelial tumors of the liver 49
Space-occupying (malignant) lesions of the liver 49
Low p27 expression is an independent predictor of survival for patients with either hilar or peripheral intrahepatic cholangiocarcinoma 46
Benign lesions of the liver 45
Early-stage focal nodular hyperplasia: US/CT/MR features correlated with histology 38
Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis 38
Totale 10.953
Categoria #
all - tutte 33.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.084 0 29 85 119 93 44 28 67 31 62 355 171
2022/20231.410 187 213 72 169 89 96 39 80 254 28 96 87
2023/2024281 27 70 16 26 21 47 14 21 8 13 9 9
2024/20251.457 37 285 140 117 213 87 63 29 17 128 31 310
2025/20263.360 269 292 369 254 355 201 295 119 742 244 125 95
2026/2027168 61 107 0 0 0 0 0 0 0 0 0 0
Totale 10.953